Bio-Techne Corp logo

Bio-Techne Corp

NAS:TECH (USA)   Ordinary Shares
$ 63.52 -0.17 (-0.27%) 10:08 PM EST
46.03
P/B:
5.08
Enterprise V:
$ 10.42B
Volume:
984.80K
Avg Vol (2M):
1.06M
Also Trade In:
Volume:
984.80K
Avg Vol (2M):
1.06M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for TECH ( Bio-Techne Corp ) from 1992 to Apr 25 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Bio-Techne stock (TECH) PE ratio as of Apr 25 2024 is 46.03. More Details

Bio-Techne Corp (TECH) PE Ratio (TTM) Chart

To

Bio-Techne Corp (TECH) PE Ratio (TTM) Historical Data

Total 1214
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Bio-Techne PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-25 46.0 2024-02-20 51.0
2024-04-23 46.1 2024-02-16 51.9
2024-04-22 45.5 2024-02-15 51.6
2024-04-19 45.0 2024-02-14 50.8
2024-04-18 45.1 2024-02-13 48.9
2024-04-17 45.5 2024-02-12 50.7
2024-04-16 46.4 2024-02-09 49.2
2024-04-15 47.5 2024-02-08 49.3
2024-04-12 48.4 2024-02-07 48.1
2024-04-11 49.9 2024-02-06 48.8
2024-04-10 50.4 2024-02-05 48.4
2024-04-09 51.6 2024-02-02 47.8
2024-04-08 49.4 2024-02-01 49.7
2024-04-05 48.5 2024-01-31 51.0
2024-04-04 48.6 2024-01-30 52.7
2024-04-03 49.2 2024-01-29 52.7
2024-04-02 49.8 2024-01-26 52.6
2024-04-01 50.3 2024-01-25 51.5
2024-03-28 51.0 2024-01-24 51.5
2024-03-27 50.3 2024-01-23 52.5
2024-03-26 49.6 2024-01-22 52.2
2024-03-25 50.2 2024-01-19 51.0
2024-03-22 51.8 2024-01-18 50.6
2024-03-21 52.4 2024-01-17 50.6
2024-03-20 52.1 2024-01-16 51.8
2024-03-19 51.3 2024-01-12 52.3
2024-03-18 52.1 2024-01-11 53.0
2024-03-15 52.5 2024-01-10 53.0
2024-03-14 51.6 2024-01-09 52.2
2024-03-13 52.5 2024-01-08 52.8
2024-03-12 53.7 2024-01-05 51.5
2024-03-11 54.4 2024-01-04 52.5
2024-03-08 55.9 2024-01-03 52.3
2024-03-07 55.8 2024-01-02 55.6
2024-03-06 54.1 2023-12-29 55.9
2024-03-05 53.2 2023-12-28 56.7
2024-03-04 54.3 2023-12-27 51.4
2024-03-01 53.9 2023-12-26 51.3
2024-02-29 53.3 2023-12-22 51.0
2024-02-28 53.9 2023-12-21 51.1
2024-02-27 53.0 2023-12-20 49.9
2024-02-26 52.1 2023-12-19 50.9
2024-02-23 51.9 2023-12-18 50.0
2024-02-22 52.0 2023-12-15 50.0
2024-02-21 52.0 2023-12-14 49.4

Bio-Techne Corp (TECH) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Bio-Techne Corp logo
Bio-Techne Corp
NAICS : 325414 SIC : 2836
ISIN : US09073M1045

Share Class Description:

TECH: Ordinary Shares
Description
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.